Welcome to EpilepsyU.com a social network dedicated to the epilepsy community

Share This Post

Epilepsy / Global / News

‘Epilepsy cure not accessible in poor nations’

More than 60 per cent of people in low- and lower-middle income regions are not accessing any appropriate epilepsy treatment, a new study in the Lancet has revealed.
According to a paper to be published as part of the Lancet series on epilepsy, the number of people with epilepsy in low- and lower-middle-income countries (LLMICs) is more than double that in higher-income nations, and more than 60 per cent of people in these regions are not accessing any appropriate epilepsy treatment.
The paper highlights the fact that the burden of epilepsy in LLMICs is under-acknowledged by health agencies, despite the fact that treatments for this disorder are highly cost-effective.
According to lead author Prof. Charles Newton of the department of psychiatry, University of Oxford, “Deriving accurate figures on the epidemiology of epilepsy in low- and lower-middle income countries is very difficult — there have been very few surveys to gather the sort of data we need, and such studies tend to be expensive, especially for countries whose health research funding is likely to be very limited.”
“However, experts say that the research shows that the burden of epilepsy in these regions is at least double that found in high-income countries, and sadly, adequate facilities for diagnosis, treatment and ongoing management of epilepsy are virtually non-existent in many of the world’s poorest regions.
“Many people with epilepsy or their families do not even know that they have a disorder that can be controlled with biomedical treatment, so it is vitally important that awareness is raised and medical care improved in these regions,” added Prof. Newton.
The authors suggest that the higher incidence of risk factors for epilepsy — such as head trauma, poor neonatal care, and infections such as neurocysticercosis (pork tapeworm) and onchocerciasis (river blindness) — are probably responsible for the high numbers of people with epilepsy in these regions.
They highlight several ways in which epilepsy care could be improved at low cost, including potentially by engaging traditional healers — who for many people are the only point of care for epilepsy.

Source: The Asian Age

Share This Post

1 Comment

  1. Do drug companies supply as readily all across the world? By this article… that would be a no.

Comments are now closed for this post.